Aileron Therapeutics, Inc.: Aileron Therapeutics Announces a

BOSTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients'

Related Keywords

Boston , Massachusetts , United States , Alexander Lobo , Liz Melone , Exchange Commission , Drug Administration , Computershare Trust Company Inc , Nasdaq , Nasdaq Capital Market , Computershare Trust Company , Private Securities Litigation Reform Act , United States Food , Aileron , Herapeutics , Nnounces , Reverse , Stock , Split ,